Infectious Mimics of Inflammatory Bowel Disease

Nicole C Panarelli1

  • 1Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, New York.

Insights

Distinguishing inflammatory bowel disease (IBD) from mimics is challenging. Pathologists must recognize infections mimicking IBD for accurate diagnosis and patient care.

Area of Science:

  • Gastroenterology
  • Pathology
  • Infectious Diseases

Background:

  • Distinguishing inflammatory bowel disease (IBD) from its mimics presents a diagnostic challenge for surgical pathologists.
  • Gastrointestinal infections can exhibit inflammatory patterns that overlap with typical IBD findings.
  • Clinical assays for infections may be unavailable or inconclusive at the time of histologic evaluation.

Purpose of the Study:

  • To review bacterial, fungal, and protozoal infections that can mimic IBD.
  • To enhance surgical pathologists' knowledge of infectious mimics of IBD.
  • To aid in generating accurate differential diagnoses and guiding clinical follow-up.

Main Methods:

  • Literature review of infectious enterocolitides.
  • Analysis of histologic patterns overlapping with IBD.
  • Discussion of diagnostic challenges and ancillary studies.

Main Results:

  • Several bacterial, fungal, and protozoal infections can present with histologic features similar to IBD.
  • Clinical test results may not always be timely or indicative of current infection.
  • Knowledge of these mimics is crucial for accurate pathological assessment.

Conclusions:

  • Surgical pathologists need awareness of infections that simulate IBD.
  • Accurate differential diagnosis requires considering infectious etiologies.
  • Prompt clinical follow-up is essential when IBD mimics are suspected.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
318
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
233
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
495
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
181
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
369
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
160